[to top of second column]
"We're also hoping to see some improvement in visual acuity, but that's a bonus," said Dr. Robert Lanza, ACT's chief scientific officer.
The research will be performed at medical centers in Massachusetts, New Jersey and Oregon, ACT said.
Stephen Rose, chief research officer of the Foundation Fighting Blindness, said his group is "very, very glad" that ACT has permission to begin the study.
Stargardt disease: http://bit.ly/bioNHS
Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
< Recent articles
Back to top
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Law & Courts |
Spiritual Life |
Health & Fitness |
Calendar | Letters to the Editor